Featured Research

from universities, journals, and other organizations

Creating new bone tissue generation technique

Date:
April 10, 2014
Source:
University of Texas at Arlington
Summary:
Researchers are investigating whether bone grown from the body's own stem cells can replace traditional types of bone grafting. The process, which has been successful in previous lab experiments, uses biodegradable polymer scaffolding material and bone morphogenetic protein, or BMP, which was inserted into the abdomen of mice to attract stem cells that in turn produced bone. BMPs are proteins known to promote bone growth.

Dr. Liping Tang, left, bioengineering chair and professor, and Dr. Joseph Borrelli, chair of orthopedics for Texas Health Arlington Memorial, are lead investigators of the research project studying whether bone tissue can be created from a patient's own stem cells.
Credit: Image courtesy of University of Texas at Arlington

UT Arlington and Texas Health Arlington Memorial Hospital are investigating whether bone grown from the body's own stem cells can replace traditional types of bone grafting.

The process, which has been successful in previous lab experiments, uses biodegradable polymer scaffolding material and bone morphogenetic protein, or BMP, which was inserted into the abdomen of mice to attract stem cells that in turn produced bone. BMPs are proteins known to promote bone growth. The research is detailed in a new paper, "Tissue Engineering Bone Using Autologous Progenitor Cells in the Peritoneum," published by the online journal PLoS One.

Liping Tang, UT Arlington bioengineering chair and professor, and Dr. Joseph Borrelli, chair of orthopedics for Texas Health Arlington Memorial, co-authored the paper and are lead investigators of the research project.

Tang said the process will allow surgeons to establish a "mini-bioreactor" in a patient's own body. Scientists determined that the abdomen of a mouse effectively mimics the traumatic and foreign body environmental response that takes place during various bone repair procedures in humans. Bone tissue can be generated in a few days through the process, he said, rather than the weeks or months existing processes take in a lab setting.

"This research will help us to formalize a specific type of scaffolding mixture that could eliminate the use of current bone grafting techniques," Borrelli said.

The procedure could help with open bone fractures, osteomyelitis, fractures that fail to heal, congenital malformations, tumors and, in a more general sense, perhaps osteoporosis.

The goal is to use the body's own healing capacity in bone repair, Borrelli said. For instance, today if a patient suffers from a bone defect or complex tibia fracture, a surgeon may perform an iliac crest bone graft, taking bone from the pelvis.

During the bone graft procedure, the surgeon uses a mechanism that scrapes or shaves bone from the pelvis. The bone shavings are then placed directly into the defect or combined with other proteins. If successful, the research involving Borrelli and Tang will eliminate the grafting technique altogether.

Borrelli said the current grafting procedure has a 25 percent complication rate. He said the new procedure will help curtail the complication rate associated with bone grafting and reduce medical costs.

"In the future, a physician will be able to inject the scaffolding material with the ideal protein into the area where the patient's bone needs to grow or repair, and the patient's cells will never have to leave the body," Borelli said. "It will cut down on cost. It will cut down on surgery time. It will enhance patient comfort, too."

Khosrow Behbehani, dean of the UT Arlington College of Engineering, said the collaboration between the hospital and the university is the kind of collaboration that can lead to innovation in health care.

"Partners like Texas Health Arlington Memorial keep our researchers focused on goals that will help people," Behbehani said. "The work by Dr. Tang and Dr. Borrelli holds the promise of a medical advancement that can save patients time and money and improve treatment."

The research team said the process could become an outpatient procedure in the future.

Texas Health Arlington Memorial is funding $90,000 to support further research on this and other clinically relevant projects. This money will also pay for a doctoral student in Tang's lab.

"We couldn't think of a better collaborative project to be a part of," said Kirk King, Texas Health Arlington Memorial president. "By working with talented individuals at UT Arlington, we're helping advance science with the ultimate goal of enhancing health care to improve an individual's quality of life. It's a challenging task but one we'll be honored to see come to fruition."


Story Source:

The above story is based on materials provided by University of Texas at Arlington. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jinhui Shen, Ashwin Nair, Ramesh Saxena, Cheng Cheng Zhang, Joseph Borrelli, Liping Tang. Tissue Engineering Bone Using Autologous Progenitor Cells in the Peritoneum. PLoS ONE, 2014; 9 (3): e93514 DOI: 10.1371/journal.pone.0093514

Cite This Page:

University of Texas at Arlington. "Creating new bone tissue generation technique." ScienceDaily. ScienceDaily, 10 April 2014. <www.sciencedaily.com/releases/2014/04/140410095651.htm>.
University of Texas at Arlington. (2014, April 10). Creating new bone tissue generation technique. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/04/140410095651.htm
University of Texas at Arlington. "Creating new bone tissue generation technique." ScienceDaily. www.sciencedaily.com/releases/2014/04/140410095651.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins